COMMUNIQUÉS West-GlobeNewswire

Meliora Healthcare Welcomes Dr. Scott Thompson
20/07/2026
NAPLES, Fla., July 20, 2026 (GLOBE NEWSWIRE) -- Meliora Healthcare is pleased to announce that Board-certified orthopedic surgeon Scott Thompson, MD has joined the practice’s care team and is now accepting new patients [...]
Supreme Court of Canada Upholds Prohibition on Medical Treatment Patents
20/07/2026
MONTREAL, July 20, 2026 (GLOBE NEWSWIRE) -- The Supreme Court of Canada released its highly anticipated decision in Pharmascience Inc. v. Janssen Inc. , which addresses the validity of Janssen’s patent relating to the [...]
Virbac: solid growth of +7.4% at CERS in H1 2026, fueled by double-digit growth of our Supercharge4 platforms
20/07/2026
First half 2026 revenue reached €768m : +7.4% at constant exchange rate and scope (CERS) vs H1 2025 +4.0% at actual rates impacted by currency headwinds Balanced growth in both segments : companion animal +10.0% and [...]
A Father's Gift, A World First: Six-Year-Old Becomes First Patient to Receive a Liver Transplant Through a Single Robotic Incision
20/07/2026
RIYADH, Saudi Arabia, July 20, 2026 (GLOBE NEWSWIRE) -- A father's decision to give part of his liver to save his son has resulted in a global medical first. King Faisal Specialist Hospital and Research Centre (KFSH) [...]
New resources on the way for BC farms under pressure from pests and disease
20/07/2026
VANCOUVER, British Columbia, July 20, 2026 (GLOBE NEWSWIRE) -- British Columbia is home to a prolific fruit and vegetable production sector, satisfying local consumers and exporting $1.2 billion in products to markets [...]
Conceivable Life Sciences Strengthens Senior Leadership Team to Support IVI RMA Partnership and U.S. Launch
20/07/2026
Julie O'Shaughnessy named President, Vincent Payet named SVP of Clinical Operations & Partner Success to support AURA's US commercial launch NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Conceivable Life Sciences, the [...]
Route 92 Medical Celebrates the 200th Patent for its Neurovascular Intervention Portfolio
20/07/2026
New global patents protect Route 92 Medical’s ongoing innovation as the company works to address critical unmet needs in neurovascular treatment WEST JORDAN, Utah, July 20, 2026 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc [...]
La Cour suprême du Canada confirme l’interdiction des brevets sur les traitements médicaux
20/07/2026
MONTRÉAL, 20 juill. 2026 (GLOBE NEWSWIRE) -- La Cour suprême du Canada a rendu sa décision très attendue dans l’affaire Pharmascience Inc. c. Janssen Inc. , qui porte sur la validité du brevet de Janssen relatif au [...]
Zealand Pharma: Transactions related to share buy-back program (week 29, 2026)
20/07/2026
Company announcement No. 33 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 29, 2026) Copenhagen, Denmark, July 20, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: [...]
Virbac: croissance solide de +7,4 % à PCC au premier semestre 2026, portée par la hausse à deux chiffres de nos plateformes Supercharge⁴
20/07/2026
Au premier semestre 2026, le chiffre d'affaires atteint 768 M€ : +7,4 % à PCC par rapport au premier semestre 2025 +4,0 % à taux réels, impacté par des effets de change défavorables Une croissance équilibrée sur les [...]
Northwestern Medicine Announces the Robert Havey, MD, Institute for Primary Care
20/07/2026
CHICAGO, July 20, 2026 (GLOBE NEWSWIRE) -- Northwestern Medicine today announced the launch of the Northwestern Medicine Robert Havey, MD, Institute for Primary Care, a transformative new institute dedicated to [...]
Monopar Advances Launch Readiness with Addition of Veteran Commercial Executive Nicole Sweeny to Board of Directors and Expansion of Commercial Leadership Team
20/07/2026
WILMETTE, Ill., July 20, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with [...]
Novo Nordisk A/S - share repurchase programme
20/07/2026
Bagsværd, Denmark, 20 July 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) [...]
Belite Bio Announces Oral Presentation at the ASRS Annual Meeting Featuring Additional Positive Secondary Endpoint Data from the Phase 3 Trial of Tinlarebant in Stargardt Disease Type 1
20/07/2026
Tinlarebant is the first therapeutic candidate to demonstrate clinical efficacy in Stargardt disease type 1, having met the primary efficacy endpoint, reduction in lesion growth Presentation to include positive update [...]
MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29
20/07/2026
MARIETTA, Ga., July 20, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second quarter ended June 30 [...]
ORIC® Pharmaceuticals Announces Three Presentations at the European Society for Medical Oncology (ESMO) Congress 2026
20/07/2026
Enozertinib poster presentation to highlight data from an ongoing Phase 1b trial in first-line EGFR atypical NSCLC Rinzimetostat trial-in-progress poster presentation to highlight the ongoing Himalayas-1 Phase 3 study [...]
Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston
20/07/2026
New headquarters reflects Collegium's long-term vision and commitment to Massachusetts STOUGHTON, Mass., July 20, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) a leading biopharmaceutical [...]
DLH to Announce Fiscal 2026 Third Quarter Financial Results
20/07/2026
ATLANTA, July 20, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital [...]
Samsung Bioepis and Harrow Present Interim Data from a Large-Scale Post-Marketing Surveillance Study on SB11 (BYOOVIZ® / AMELIVU®), a Biosimilar to Lucentis (ranibizumab), at ASRS 2026
20/07/2026
A real-world PMS study based on a large population demonstrates comparable safety profile of SB11 (BYOOVIZ ® / AMELIVU ® ) to reference ranibizumab In treatment-naïve patients, SB11 provided functional and anatomical [...]

Pages